The use of macrolides in respiratory tract infections

Area of Science:

• Pharmacology
• Infectious Diseases
• Respiratory Medicine

Background:

• Macrolides have been utilized for over four decades, with increasing application in treating respiratory tract infections.
• Recent advancements have introduced newer macrolide antibiotics with enhanced oral absorption, improved gastrointestinal tolerance, and increased drug concentration at infection sites.

Purpose of the Study:

• To evaluate the efficacy and safety of newer macrolides in treating common respiratory tract infections.
• To assess the pharmacokinetic advantages and limitations of macrolides in respiratory infection therapy.

Main Methods:

• Comparative studies assessing the effectiveness of newer macrolides against conventional therapies.
• Analysis of pharmacokinetic properties influencing macrolide dosing and efficacy.
• Review of clinical data regarding side-effect profiles and bacterial resistance patterns.

Main Results:

• Newer macrolides demonstrate comparable efficacy to conventional treatments for acute otitis media, sinusitis, and pharyngitis, with a low incidence of adverse effects.
• Pharmacokinetic properties allow for simplified dosing regimens.
• Marginal activity against severe Haemophilus influenzae and lack of activity against Klebsiella limit their use as monotherapy in severe pneumonia or in immunocompromised patients.

Conclusions:

• Newer macrolides are effective and well-tolerated options for many common respiratory tract infections.
• Bacterial resistance and spectrum limitations necessitate judicious use, particularly in severe cases or specific patient populations.